[Date Prev][Date Next][Thread Prev][Thread Next][Date Index][Thread Index]

More on the 5 year marketing exclusivity and Nevirapine in Thailand

To: Multiple recipients of list IP-HEALTH <ip-health@essential.org>,Multiple recipients of list PHARM-POLICY <pharm-policy@essential.org>
Subject: More on the 5 year marketing exclusivity and Nevirapine in Thailand
From: Thiru Balasubramaniam <thiru@cptech.org>
Date: Fri, 17 Dec 1999 16:11:22 -0500
Delivered-To: pharm-policy@venice.essential.org
Organization: Consumer Project on Technology
Sender: tb@genoa.essential.org

Just a small clarification.  Boehringer Ingelheim is the patent owner of
Nevirapine.  Boehringer Ingelheim is a German company.


Thiru Balasubramaniam
Consumer Project on Technology

Prev by Date: Khalil Elouadighi on Clinton Annoucement
Prev by thread: More on the 5 year marketing exclusivity and Nevirapine in Thailand
Next by thread: Khalil Elouadighi on Clinton Annoucement
Index(es):
- Date
- Thread